Investors may believe Sichuan Goldstone Asia Pharmaceutical ...
Investors may believe Sichuan Goldstone Asia Pharmaceutical Inc.'s strong earnings growth could underperform the market, causing its low P/E ratio. If recent earnings trends persist, a significant share price rise seems unlikely.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000159fc47e4677ac.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment